Correction: Exploring the prognostic value of combined assessment of bone marrow plasma cell morphology, Vitamin D, and interleukin-6 in multiple myeloma - Summary - MDSpire

Correction: Exploring the prognostic value of combined assessment of bone marrow plasma cell morphology, Vitamin D, and interleukin-6 in multiple myeloma

  • By

  • Ping Huang

  • Fenping Zhang

  • Yuchun Lin

  • Jie Peng

  • Zesong Yang

  • June 10, 2026

  • 0 min

Share

Objective:

To correct the ethics approval number reported in the original article due to an error.

Approach:
    Key Findings:
    • The study received ethics approval from the First Affiliated Hospital of Chongqing Medical University and Fengdu County Traditional Chinese Medicine Hospital.
    • Written informed consent was obtained from all participants.
    Interpretation:

    Conclusion:

    The original version of the article has been updated to reflect the corrected ethics approval number.

    Sources:

Original Source(s)

Correction: Exploring the prognostic value of combined assessment of bone marrow plasma cell morphology, Vitamin D, and interleukin-6 in multiple myeloma

  • by Ping Huang, Fenping Zhang, Yuchun Lin, Jie Peng, Zesong Yang

  • June 10, 2026

Related Content

Editorial: A new perspective on the importance of dendritic cells in cancer immunity: from bench to patient’s bedside

A propensity score matching study on clinical characteristics and risk factors of herpes zoster in malignant tumor

Experiences and expert panel consensus on bridging therapy before anti-BCMA CAR-T cell therapy in multiple myeloma